1991
DOI: 10.1016/0264-410x(91)90215-r
|View full text |Cite
|
Sign up to set email alerts
|

Internal image (Ab2β) anti-idiotype vaccines. Theoretical and practical aspects

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
8
0

Year Published

1993
1993
2012
2012

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(8 citation statements)
references
References 40 publications
0
8
0
Order By: Relevance
“…A true internal-image molecule can induce immune-mediated responses similar to those induced by the original antigen, and this property has, in fact, been used to produce vaccines (reviewed in refs. 5 and 6). Thus, there may be significant structural mimicry between the complementarity-determining regions (CDRs) of internal-image Ab2s and the original antigen.…”
mentioning
confidence: 99%
“…A true internal-image molecule can induce immune-mediated responses similar to those induced by the original antigen, and this property has, in fact, been used to produce vaccines (reviewed in refs. 5 and 6). Thus, there may be significant structural mimicry between the complementarity-determining regions (CDRs) of internal-image Ab2s and the original antigen.…”
mentioning
confidence: 99%
“…In addition, the epitopes recognized with these protective anti-Ids were different. As previously reported [12], although a single anti-Id antibody can be used for immunization against an infectious organism, different epitopes may be instrumental in stimulating the various aspects of immunity required for effective protection. It is possible that vaccines composed of a cocktail of the appropriate anti-Id antibodies may 187 be effective for vaccination.…”
Section: Discussionmentioning
confidence: 81%
“…These anti-idiotope antibodies have potential for use in the development of vaccines; thus it may be possible to utilize the Ab2/? for antigen mimicry and to cause the host's immune response to produce antibodies by injecting the anti-Id alone, without exposing the host to potentially dangerous antigen (Dreesman et al, 1985;Moller, 1986;Poskitt et al, 1991). We report on the production and the properties of anti-idiotypic antibodies raised against the murine monoclonal antibody ISS/32, which has been shown to possess protective activity (Ciuchini et al, 1989;Adone et al, 1991).…”
Section: Introductionmentioning
confidence: 85%